Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.

NCT04348695 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Coronavirus Infection

Interventions

DRUG: Ruxolitinib plus simvastatin
OTHER: Standard of Care

Sponsor

Fundación de investigación HM

Collaborators

[object Object]